Tyler A. Kokjohn

Midwestern University — United States

Medicine · Health Sciences

39h-index6.3kcitations92works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(55), Dementia and Cognitive Impairment Research(18), Bacteriophages and microbial interactions(13), Prion Diseases and Protein Misfolding(12), Cholinesterase and Neurodegenerative Diseases(12)

Publications92 total

APP/Aβ structural diversity and Alzheimer's disease pathogenesis
Neurochemistry International·2017· 105 citedOpen Access
Alzheimer’s disease syndrome – Recognizing the complexity of dementia
Neurological Disorders and Therapeutics·2017Open Access
Familial Presenilin Mutations and Sporadic Alzheimer’s Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?
Journal of Alzheimer s Disease·2016· 21 cited
Chemical and neuropathological analyses of an Alzheimer's disease patient treated with solanezumab.
PubMed Central·2016· 14 citedOpen Access
Biochemical Assessment of Precuneus and Posterior Cingulate Gyrus in the Context of Brain Aging and Alzheimer’s Disease
PLoS ONE·2014· 17 citedOpen Access
Neuropathological and biochemical assessments of an Alzheimer's disease patient treated with the γ-secretase inhibitor semagacestat.
PubMed·2014· 9 citedOpen Access
Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy
PLoS ONE·2013· 33 citedOpen Access
Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.
PubMed·2013· 17 citedOpen Access
Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson's Disease Cases Lacking Alzheimer's Disease Pathology
Biomarker Insights·2013· 14 citedOpen Access
Molecular Differences and Similarities between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis
Biochemistry Insights·2013· 64 citedOpen Access
Neurochemical Profile of Dementia Pugilistica
Journal of Neurotrauma·2012· 37 citedOpen Access
Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations
Neurochemistry International·2012· 66 citedOpen Access
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects
Neurological Research·2012· 65 citedOpen Access
P4‐048: Neurodegenerative‐related proteins in the evolution of the aging brain
Alzheimer s & Dementia·2012Open Access
P1‐202: Biochemical consequences of traumatic brain injury in dementia pugilistica
Alzheimer s & Dementia·2012
Morphological and Pathological Evolution of the Brain Microcirculation in Aging and Alzheimer’s Disease
PLoS ONE·2012· 177 citedOpen Access
Biochemical and Morphological Characterization of the AβPP/PS/Tau Triple Transgenic Mouse Model and Its Relevance to Sporadic Alzheimer's Disease
Journal of Alzheimer s Disease·2011· 18 citedOpen Access
Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging
PLoS ONE·2011· 78 citedOpen Access
Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?
Alzheimer s & Dementia·2011· 29 citedOpen Access
Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease·2011· 61 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Alex E. Roher(37), Thomas G. Beach(26), Walter M. Kalback(18), Chera L. Maarouf(16), Dean C. Luehrs(15), Yu‐Min Kuo(13), Chera L. Esh(11), Mark R. Emmerling(10), Ian D. Daugs(9), Marwan N. Sabbagh(9), Lucia I. Sue(9), Eduardo M. Castaño(7), Douglas G. Walker(6), Rebekah Patton(5), Gregory D. Van Vickle(4), Daniel C. Brune(4), John Lopez(4), Robert V. Miller(4), Jesse M. Hunter(4), Zsolt Garami(4)